活体肾捐献者与受者生物学关系及不同种族终末期肾病风险
该回顾性队列研究纳入1987至2017年美国143,750例活体肾捐献者,按捐献者与受者生物学关系及种族分析终末期肾病(ESKD)风险。中位随访12年,采用竞争风险生存分析。结果显示,不同种族和关系类别间ESKD风险差异达数量级,如亚洲同卵双胞胎捐献者风险为无血缘关系者的259.4倍。
要点
- 活体肾捐献者ESKD风险因与受者生物学关系及种族而异。
- 亚洲同卵双胞胎捐献者风险比无血缘关系者高259.4倍(95%CI 19.5-3445.6)。
- 黑人同卵双胞胎、同胞、子女、父母捐献者风险均显著增高。
核心结论
- 亚洲、黑人和白人捐献者的ESKD风险在不同捐献者-受者关系类型间存在显著差异。
- 这些发现需更稳健数据进一步验证以更好指导临床实践指南。
研究设计与样本
- 回顾性队列研究,纳入1987至2017年美国143,750例活体肾捐献者。
- 暴露为捐献者与受者的生物学关系,结局为ESKD,通过链接国家透析和移植登记处确认。
- 中位随访12年(四分位距6-18,最长30年),采用考虑死亡竞争风险的生存分析方法。
主要发现
- 亚洲捐献者:同卵双胞胎风险为无血缘关系者的259.4倍(95%CI 19.5-3445.6),全同胞4.7倍(95%CI 0.5-41.0),子女3.5倍(95%CI 0.6-39.5),父母1.0,半同胞或其他生物学亲属1.0。
- 黑人捐献者:同卵双胞胎风险为无血缘关系者的22.5倍(95%CI 4.7-107.0),全同胞4.1倍(95%CI 2.1-7.8),子女2.7倍(95%CI 1.4-5.4),父母3.1倍(95%CI 1.4-6.8),半同胞或其他生物学亲属1.3倍(95%CI 0.5-3.3)。
- 白人捐献者:同卵双胞胎风险为无血缘关系者的3.5倍(95%CI 0.5-25.3),全同胞2.0倍(95%CI 1.4-2.8),子女1.4倍(95%CI 0.9-2.3),父母2.9倍(95%CI 2.0-4.1),半同胞或其他生物学亲属0.8倍(95%CI 0.3-1.6)。
临床怎么用
- 临床评估活体肾捐献者时,应结合其与受者的生物学关系及种族综合评估ESKD风险。
- 当前临床实践指南未涉及捐献者-受者生物学关系这一风险因素,需考虑纳入。
局限性
- 某些种族和关系组样本量不足。
- 缺乏与受者无生物学关系的捐献者的家族性肾脏病史数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Risk factors for kidney failure are the basis of live kidney donor candidate evaluation. We quantified risk for end-stage kidney disease (ESKD) by the biological relationship of the donor to the recipient, a risk factor that is not addressed by current clinical practice guidelines. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: A cohort of 143,750 US kidney donors between 1987 and 2017. EXPOSURE: Biological relationship of donor and recipient. OUTCOME: ESKD. Donors' records were linked to national dialysis and transplantation registries to ascertain development of the outcome. ANALYTIC APPROACH: Donors were observed over a median of 12 (interquartile range, 6-18; maximum, 30) years. Survival analysis methods that account for the competing risk for death were used. RESULTS: Risk for ESKD varied by orders of magnitude across donor-recipient relationship categories. For Asian donors, risks compared with unrelated donors were 259.4-fold greater for identical twins (95% CI, 19.5-3445.6), 4.7-fold greater for full siblings (95% CI, 0.5-41.0), 3.5-fold greater for offspring (95% CI, 0.6-39.5), 1.0 for parents, and 1.0 for half-sibling or other biological relatives. For black donors, risks were 22.5-fold greater for identical twin donors (95% CI, 4.7-107.0), 4.1-fold for full siblings (95% CI, 2.1-7.8), 2.7-fold for offspring (95% CI, 1.4-5.4), 3.1-fold for parents (95% CI, 1.4-6.8), and 1.3-fold for half-sibling or other biological relatives (95% CI, 0.5-3.3). For white donors, risks were 3.5-fold greater for identical twin donors (95% CI, 0.5-25.3), 2.0-fold for full siblings (95% CI, 1.4-2.8), 1.4-fold for offspring (95% CI, 0.9-2.3), 2.9-fold for parents (95% CI, 2.0-4.1), and 0.8-fold for half-sibling or other biological relatives (95% CI, 0.3-1.6). LIMITATIONS: Insufficient sample size in some race and relationship groups. Absence of data for family history of kidney disease for donors biologically unrelated to their recipients. CONCLUSIONS: Marked differences in risk for ESKD across types of donor-recipient relationship were observed for Asian, black, and white donors. These findings warrant further validation with more robust data to better inform clinical practice guidelines.
引用
- Muzaale AD, Massie AB, Al Ammary F, et al. Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups. Am J Kidney Dis. 2019. PMID: 31732232. doi:10.1053/j.ajkd.2019.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。